{"url_path":"/sec/imvt/10-k/2026/item-14","section_key":"item-14","section_title":"Item 14 Principal Accountant Fees and Services","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1764013/0001764013-26-000064-index.html","accession_number":"0001764013-26-000064","cik":"0001764013","ticker":"IMVT","issuer_name":"Immunovant, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1764013/0001764013-26-000064-index.html","primary_entity_key":"0001764013","primary_entity_name":"Immunovant, Inc."},"word_count":45,"has_tables":true,"body_markdown":"Item 14. Principal Accountant Fees and Services\n\nThe information required by this item will be contained in our 2026 Proxy Statement under the caption “Ratification of Selection of Independent Registered Public Accounting Firm” and is incorporated herein by reference.\n\n145\n\n[Table of Contents](#iffdf096b0e874ebba3b8e07ac3efab3a_7)\n\nPART IV"}